Beranda › Diabetes Tipe 2 › Arizona › Tucson
Uji klinis Diabetes Tipe 2 di Tucson, AZ
10 studi untuk Diabetes Tipe 2 mencari peserta di lokasi sekitar Tucson (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Menerima pesertaFase 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Menerima pesertaFase 3
- Arizona Clinical Trials, Tucson
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Menerima pesertaSukarelawan sehat diterima
- Noble Clinical Research, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Menerima pesertaFase 3
- Tucson Clinical Research Institute, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Menerima pesertaFase 3
- Research Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Menerima pesertaFase 3
- AURORA-2 Clinical Site, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Menerima pesertaFase 3
- Arizona Clinical Trials, Tucson
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Menerima pesertaFase 2
- Arizona Clinical Trials - Broadway, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Menerima pesertaFase 2
- Pima Heart, Tucson
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Menerima pesertaFase 3
- University of Arizona, Tucson
Uji klinis Diabetes Tipe 2 di kota lain
- San Antonio, TX37 studi
- Houston, TX31 studi
- Orlando, FL24 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Chicago, IL19 studi
- Dallas, TX19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- Atlanta, GA17 studi
- San Diego, CA17 studi
- Los Angeles, CA16 studi
Studi lain di Tucson
- Kanker Payudara20 studi
- Kanker Paru Non-Sel Kecil17 studi
- Obesitas17 studi
- Kelebihan Berat Badan15 studi
- Kanker Metastatik14 studi
- Kanker (semua jenis)12 studi
- Penyakit Kardiovaskular12 studi
- Kanker Kolorektal11 studi
- Kanker Prostat11 studi
- Penyakit Hati Steatotik10 studi
- Gagal Jantung10 studi
- Tekanan Darah Tinggi10 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.